SpaceX CEO Elon Musk suggested on X that a high-pressure nitrogen tank failure was behind the explosion of the company's massive Starship rocket.
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug’s affordability.
A growing body of research attempts to put a number on energy use and AI—even as the companies behind the most popular models keep their carbon emissions a secret.
President Donald Trump has supported use of asbestos in the past and blamed the mob for its bad reputation.
In United States v. Skrmetti, the Supreme Court ruled that Tennessee’s ban on gender-affirming care for minors was not unconstitutional—the first case of its kind on which the court has ruled.
A new study reveals the key lies not in the production of a regrowth molecule, but in that molecule's controlled destruction. The discovery could inspire future regenerative medicine.
Jules Gill-Peterson doesn’t want to fight for trans joy. She wants to fight for what trans people really need: resources, hormones, and surgery. Her latest arena? The US Supreme Court.
An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could eventually be an alternative or add-on to popular GLP-1 medications.
Recent flybys of the fiery world refute a leading theory of its inner structure—and reveal how little is understood about geologically active moons.
Facilities that make wood pellets have a track record of catching alight. Yet there are plans to build several near Yosemite’s tinderbox forests.